Related Experiment Videos
Platelet aggregation size and volume in chronic obstructive pulmonary disease
I Onder1, S Topcu, H S Dökmetas
1Department of Internal and Respiratory Medicine, Faculty of Medicine, Cumhuriyet University Sivas/Turkey.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy
|January 1, 1997
Summary
Hypoxia in chronic obstructive pulmonary disease (COPD) patients significantly alters thrombocytes, decreasing platelet count and increasing aggregation. Oxygen and antiplatelet therapy may improve outcomes for these patients.
Area of Science:
- Pulmonary Medicine
- Hematology
Background:
- Chronic obstructive pulmonary disease (COPD) is associated with various systemic complications.
- The impact of hypoxia on thrombocytes (platelets) in COPD patients requires further elucidation.
Purpose of the Study:
- To investigate the effects of hypoxia on thrombocyte parameters in patients with COPD.
- To compare these effects between hypoxic and non-hypoxic COPD patients and healthy individuals.
Main Methods:
- Study included 15 hypoxic COPD patients, 15 non-hypoxic COPD patients, and 10 healthy controls.
- Assessed hemoglobin, hematocrit, PaCO2, blood pH, FEV1, FVC, and PaO2.
- Analyzed thrombocyte count, mean platelet volume, and platelet aggregation.
Main Results:
- Significant differences in FEV1, FVC, and PaO2 between groups; no significant differences in hemoglobin, hematocrit, or PaCO2 between COPD groups.
- Thrombocyte aggregation significantly increased in both hypoxic and non-hypoxic COPD groups compared to controls.
- Hypoxic COPD patients showed a significant decrease in platelet count and an increase in mean platelet volume.
Conclusions:
- Hypoxia in COPD patients is linked to decreased thrombocyte count and increased platelet volume and aggregation.
- Oxygen supplementation and antiplatelet therapy could potentially improve survival and quality of life in hypoxic COPD patients.